Posts belonging to Category Reverse Convertibles



Brokers Unload More Structure Notes on Investors

 

Investors are urged to be cautious about purchasing structured notes. Brokers are on track to sell more than $10 billion of structured notes linked to the S&P 500 stock index this year. In fact, sales will reach the highest levels in at least three years, according to Bloomberg (“Structured Notes Tied to S&P 500 Set […]

Insurance Companies Raise Red Flags on Certain Alternative Investments

 

The recent actions of errors and omissions insurance carriers should serve as a major red flag to investors. Many of these carriers are refusing to issue coverage for sales of certain alternative investments. In other words, these carriers have determined that the risk of loss associated with the sale of certain alternative investments is too […]

Hedge Funds Hit Hard by Commodities Investments

 

Slowing U.S. jobs growth, slowing growth in China, concerns about another global recession, and uncertainties relating to the Euro crisis, have turned commodities bulls into bears as hedge funds beat a hasty retreat from commodities for the third consecutive month, according to Businessweek (“Hedge Funds in Longest Rout Since Global Recession,” by Tony C. Dreibus).

Alternative Investments Are No Investment Panacea

 

Financial advisers need to know that dangers lurk in the complex world of alternative investments and they must disclose these dangers to their clients. At present, many investment advisers are under pressure to sell alternative investments and are doing so in greater numbers than ever before. Alternative investments can include virtually any investment that is […]

Conflicts of Interest and Complex Products Highlight Concerns about Wall Street

 

Broker-dealers’ conflicts of interest and the proliferation of complex financial products being sold by financial advisers are the top areas of concern to the Financial Industry Regulatory Authority (FINRA), according InvestmentNews (“Ketchum: Finra’s focus on conflicts of interest compounding,” by Bruce Kelly).

Why Simply ‘Looking Into’ Wall Street’s Failure To Perform Adequate Due Diligence Isn’t Enough

 

The Securities and Exchange Commission has identified broker-dealer due diligence as an area of high risk. Before recommending any investment, a brokerage firm is required by law to have a reasonable basis for believing the investment is suitable for customers to whom the investment is recommended, and for understanding all the material facts (the pros […]

Regulators Eye the Role of Investment Wholesalers in Providing Misleading Disclosures to Investors

 

The Financial Industry Regulatory Authority (FINRA) is showing stepped-up interest in the role of broker-dealers and individuals that act as wholesalers in the sale of private (Reg D) offerings that clients and often brokers do not fully understand. (See InvestmentNews article by Bruce Kelly entitled “Finra eyes wholesalers’ role in vending.”

Chicago Professors Argue That Governmental Approval Should Be Required For Wall Street’s Exotic Financial Products

 

Wall Street is peddling snake oil ? new financial products that are the equivalent of bottles of medicine with labels like “Dr. Bartlett’s Beneficent Balm ? Boon to Mankind” ? and they should be regulated as such, according to University of Chicago professors Eric A. Posner and E. Glen Weyl. The FDA protects consumers from […]

Many Exotic CDs and Structured Notes Involve High Costs and Serious Risks

 

With interest rates stuck at record lows, and retirees or those on the brink of retirement looking are for higher yields, Wall Street has capitalized on this dilemma by selling an array of alternative products like “structured notes” that promise higher yields but come with higher (often undisclosed) risks, and by marketing dividend stocks as […]

Securities Regulators Set High Standards for Firms Selling Complex Investments

 

The Financial Industry Regulatory Authority has issued a Regulatory Notice (12-03, Jan. 2012) to “remind” its member firms of their sales practice obligations with regard to complex products, and to provide them “guidance” in exercising heightened scrutiny and supervision over marketing and sales of complex products. Complex products are not defined in the Notice, but […]